{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:29:02Z","timestamp":1793503742948,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.hpb.2025.08.001","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T06:39:04Z","timestamp":1754721544000},"page":"1418-1426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["International survey on the use of preoperative chemotherapy in the setting of multimodality management of intrahepatic cholangiocarcinoma"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-8092","authenticated-orcid":false,"given":"Elena","family":"Panettieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3310-8088","authenticated-orcid":false,"given":"Agostino M.","family":"De Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4643-0634","authenticated-orcid":false,"given":"Eduardo A.","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5550-1756","authenticated-orcid":false,"given":"Alessandro","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1596-2862","authenticated-orcid":false,"given":"Francesco","family":"Ardito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2087-2589","authenticated-orcid":false,"given":"Felice","family":"Giuliante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2025.08.001_bib1","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/cncr.32803","article-title":"Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012","volume":"126","author":"Florio","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2025.08.001_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/oncolo\/oyac150","article-title":"Temporal changes in cholangiocarcinoma incidence and mortality in the United States from 2001 to 2017","volume":"27","author":"Javle","year":"2022","journal-title":"Oncologist"},{"key":"10.1016\/j.hpb.2025.08.001_bib3","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.hpb.2025.08.001_bib4","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1200\/JCO.2011.35.6519","article-title":"Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment","volume":"29","author":"de Jong","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2025.08.001_bib5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hpb.12441","article-title":"Intrahepatic cholangiocarcinoma: expert consensus statement","volume":"17","author":"Weber","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2025.08.001_bib6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1245\/s10434-019-08067-3","article-title":"A machine-based approach to preoperatively identify patients with the Most and least benefit associated with resection for intrahepatic cholangiocarcinoma: an international multi-institutional analysis of 1146 patients","volume":"27","author":"Tsilimigras","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.001_bib7","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.1245\/s10434-023-14254-0","article-title":"Great debates: neoadjuvant therapy should be routinely given for high-risk cholangiocarcinoma","volume":"30","author":"Tran Cao","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.001_bib8","unstructured":"https:\/\/clinicaltrials.gov\/study\/NCT04308174."},{"key":"10.1016\/j.hpb.2025.08.001_bib9","unstructured":"https:\/\/www.cancer.gov\/research\/participate\/clinical-trials-search\/v?id=NCI-2023-07031."},{"key":"10.1016\/j.hpb.2025.08.001_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s13304-016-0373-0","article-title":"Liver surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it","volume":"68","author":"Torzilli","year":"2016","journal-title":"Updates Surg"},{"key":"10.1016\/j.hpb.2025.08.001_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hpb.2025.08.001_bib12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hpb.2025.08.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpsurg.2024.101639","article-title":"Development and validation of an early recurrence predictive model for intrahepatic cholangiocarcinoma based on a systematic review and meta-analysis of 17 cohorts","volume":"61","author":"Yang","year":"2024","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.hpb.2025.08.001_bib14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/bjs.10296","article-title":"Multicentre study of the impact of morbidity on long-term survival following hepatectomy for intrahepatic cholangiocarcinoma","volume":"103","author":"Doussot","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.08.001_bib15","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.hpb.2023.07.898","article-title":"Intrahepatic cholangiocarcinoma: how do hepatectomy outcomes compare to liver metastases and hepatocellular carcinoma?","volume":"25","author":"Diggs","year":"2023","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2025.08.001_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s12029-022-00820-4","article-title":"The implications of treatment delays in adjuvant therapy for resected cholangiocarcinoma patients","volume":"54","author":"Parsons","year":"2023","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.hpb.2025.08.001_bib17","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.amjsurg.2021.02.029","article-title":"Neoadjuvant chemotherapy is associated with improved survival in patients undergoing hepatic resection for intrahepatic cholangiocarcinoma","volume":"221","author":"Sutton","year":"2021","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2025.08.001_bib18","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.1245\/s10434-020-09536-w","article-title":"Time to rethink upfront surgery for resectable intrahepatic cholangiocarcinoma? Implications from the neoadjuvant experience","volume":"28","author":"Mason","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.001_bib19","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.hpb.2022.03.010","article-title":"Is it safe to administer neoadjuvant chemotherapy to patients undergoing hepatectomy for intrahepatic cholangiocarcinoma? ACS-NSQIP propensity-matched analysis","volume":"24","author":"Choi","year":"2022","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2025.08.001_bib20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.hpb.2023.01.011","article-title":"Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?","volume":"25","author":"Ayabe","year":"2023","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hpb.2025.08.001_bib21","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1245\/s10434-023-13809-5","article-title":"NEO-GAP: a single-arm, phase II feasibility trial of neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for resectable, high-risk intrahepatic cholangiocarcinoma","volume":"30","author":"Maithel","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.001_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/gutjnl-2023-330029","article-title":"British society of gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma","volume":"73","author":"Rushbrook","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.hpb.2025.08.001_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/bjs.10641","article-title":"Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma","volume":"105","author":"Le Roy","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2025.08.001_bib24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.hpb.2025.08.001_bib25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cncr.29824","article-title":"Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone","volume":"122","author":"Konstantinidis","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.hpb.2025.08.001_bib26","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejso.2023.01.006","article-title":"Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"49","author":"Jansson","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2025.08.001_bib27","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.hpb.2025.08.001_bib28","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.hpb.2025.08.001_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100377","article-title":"Setup of multidisciplinary team discussions for patients with cholangiocarcinoma: current practice and recommendations from the european network for the study of cholangiocarcinoma (ENS-CCA)","volume":"7","author":"Casadio","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.hpb.2025.08.001_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.gassur.2023.11.014","article-title":"Global practice patterns of preoperative image reconstruction for liver surgery","volume":"28","author":"Panettieri","year":"2024","journal-title":"J Gastrointest Surg"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25015527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X25015527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:57:44Z","timestamp":1793501864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X25015527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1365182X25015527"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2025.08.001","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International survey on the use of preoperative chemotherapy in the setting of multimodality management of intrahepatic cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2025.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}